Literature DB >> 29897569

A high abdominal aortic calcification score by dual X-ray absorptiometry is associated with cardiovascular events after kidney transplantation.

Stan Benjamens1,2, Robert A Pol2, Andor W J M Glaudemans1, Ivanka Wieringa3, Stefan P Berger3, Stephan J L Bakker3, Riemer H J A Slart1,4.   

Abstract

Background: Aortic calcification is associated with an increased risk for cardiovascular events in renal transplant recipients. This study focused on the association of abdominal aortic calcification (AAC) and cardiovascular events assessed using a dual-energy X-ray absorptiometry (DXA) scoring methodology for AAC.
Methods: From 2008 to 2014, renal transplant recipients referred for a DXA procedure within 6 months after transplantation were included in a retrospective, single-centre study. The primary endpoint was the occurrence of cardiovascular events, defined as myocardial infarction, cerebrovascular accident or transient ischaemic attack, after transplantation. AAC was quantified using an 8-point scoring system and patients were divided into three groups; a control group (AAC = 0), a low AAC group (AAC = 1-3) and a high AAC group (AAC = 4-8).
Results: We evaluated 701 patients, 267 (38.1%) had detectable calcifications (low AAC 190 patients, high AAC 77 patients) and 434 (61.9%) had no calcifications. Cardiovascular events were seen in 37 (8.5%) patients in the control group, in 18 (9.5%) in the low AAC group and in 20 (26.0%) in the high AAC group. Univariate Cox proportional hazards analysis of the high AAC score showed a hazard ratio (HR) of 4.23 [95% confidence interval (CI) 2.44-7.33; P < 0.01] for cardiovascular events, while results were not significant for the low AAC score. Multivariate analysis showed an independent significant association between a high AAC score and cardiovascular events [HR 2.78 (95% CI 1.05-7.64); P = 0.04]. Assessment of the continuous net reclassification index (NRI), comparing the combined clinical variables with a model of both AAC scoring and clinical variables, showed an NRI of 0.76 (95% CI 0.65-0.86; P < 0.01). Conclusions: An independent association between a high AAC score, assessed by DXA, and cardiovascular events was identified and provides an opportunity for early cardiovascular risk stratification in renal transplant recipients.

Entities:  

Mesh:

Year:  2018        PMID: 29897569     DOI: 10.1093/ndt/gfy158

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  5 in total

1.  Liver Fibrosis Scoring Systems as Novel Tools for Predicting Cardiovascular Outcomes in Patients Following Elective Percutaneous Coronary Intervention.

Authors:  Hui-Hui Liu; Ye-Xuan Cao; Jing-Lu Jin; Qi Hua; Yan-Fang Li; Yuan-Lin Guo; Cheng-Gang Zhu; Na-Qiong Wu; Run-Lin Gao; Jian-Jun Li
Journal:  J Am Heart Assoc       Date:  2021-01-28       Impact factor: 5.501

2.  Abdominal Aortic Calcification and Cardiovascular Outcomes in Chronic Kidney Disease: Findings from KNOW-CKD Study.

Authors:  Sang Heon Suh; Tae Ryom Oh; Hong Sang Choi; Chang Seong Kim; Eun Hui Bae; Kook-Hwan Oh; Joongyub Lee; Yun Kyu Oh; Ji Yong Jung; Seong Kwon Ma; Soo Wan Kim
Journal:  J Clin Med       Date:  2022-02-22       Impact factor: 4.241

3.  Vitamin K for kidney transplant organ recipients: investigating vessel stiffness (ViKTORIES): study rationale and protocol of a randomised controlled trial.

Authors:  Jennifer Susan Lees; Kenneth Mangion; Elaine Rutherford; Miles D Witham; Rosemary Woodward; Giles Roditi; Tracey Hopkins; Katriona Brooksbank; Alan G Jardine; Patrick B Mark
Journal:  Open Heart       Date:  2020-07

4.  The prognosis of kidney transplant recipients with aorto-iliac calcification: a systematic review and meta-analysis.

Authors:  Elsaline Rijkse; Jacob L van Dam; Joke I Roodnat; Hendrikus J A N Kimenai; Jan N M IJzermans; Robert C Minnee
Journal:  Transpl Int       Date:  2020-03-04       Impact factor: 3.842

Review 5.  Current Applications and Selected Technical Details of Dual-Energy X-Ray Absorptiometry.

Authors:  Piotr Sawicki; Marek Tałałaj; Katarzyna Życińska; Wojciech S Zgliczyński; Waldemar Wierzba
Journal:  Med Sci Monit       Date:  2021-06-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.